Healthcare orgs are overwhelmed by AI vendors that are 'a dime a dozen' with no reliable way to separate credible solutions from hype. Most AI startups will flop or get acquired, and healthcare margins are thin.
A curated marketplace and due-diligence service that independently evaluates healthcare AI vendors through customer reference checks, clinical outcome data verification, financial stability analysis, and peer health system reviews - like a Gartner specifically for clinical AI tools.
Freemium: free basic vendor directory, paid tier for detailed evaluation reports and advisory ($5K-25K per engagement or annual subscription)
The Reddit signals are unambiguous: procurement teams are drowning. 'Dime a dozen' vendors, thin margins leaving no room for bad bets, and genuine fear that most AI startups will fail or get acquired. CMIOs and CFOs are making $500K-$5M decisions with minimal independent data. The pain is acute, frequent, and has real financial consequences. Health systems that pick wrong waste millions and lose clinician trust in AI broadly.
TAM: ~6,000 US hospitals + ~400 health systems making AI purchasing decisions. At $5K-$25K per engagement, the initial addressable market is $30M-$150M/year for evaluation services. Adding annual subscriptions, advisory retainers, and vendor-side analytics, realistic SAM is $50M-$200M. Not a billion-dollar TAM on its own, but a strong wedge into the broader healthcare IT advisory market ($2B+). International expansion (NHS, EU health systems facing similar AI vendor overload) adds upside.
Health systems already pay $30K-$250K/year for KLAS, Gartner, and AVIA. The budget line item exists. However, the $5K-$25K per engagement pricing targets a gap: too expensive for a casual purchase but significantly cheaper than incumbent options. Mid-size health systems that can't afford KLAS/Gartner are underserved and likely willing to pay $5K-$15K for a specific vendor evaluation that prevents a $1M mistake. The ROI story writes itself. Risk: procurement budgets are under pressure and 'yet another advisory service' is a tough sell without proven credibility.
MVP is primarily a content/services business, not a complex software product. A solo dev can build: (1) a vendor directory with structured profiles, (2) a report template system, (3) a basic peer review/reference check workflow, and (4) a simple subscription/paywall. The hard part isn't tech — it's building the evaluation methodology, collecting reference data, and establishing credibility. A Next.js app with a CMS, Stripe billing, and a PDF report generator gets you to MVP in 4-6 weeks.
The gap is real and specific: NO existing player does rigorous, independent technical validation of healthcare AI vendors (bias testing, clinical outcome verification, regulatory compliance checks, startup financial viability analysis). KLAS rates deployed products retrospectively. Gartner is too slow and expensive. AVIA has conflict-of-interest concerns. Nobody serves smaller health systems affordably. Nobody covers the 500+ emerging AI startups. The 'Gartner for clinical AI' positioning is wide open.
Strong subscription mechanics: (1) vendor landscape changes monthly requiring updated evaluations, (2) health systems make multiple AI purchases per year, (3) post-deployment monitoring of vendor viability is ongoing, (4) regulatory landscape shifts constantly. Annual subscription for continuous access to updated reports and advisory is natural. The challenge is proving enough ongoing value vs. one-time report purchases.
- +Acute, validated pain point with clear willingness-to-pay signals (health systems already spend $30K-$250K/year on IT advisory)
- +Massive competition gap: no affordable, AI-specific, technically rigorous evaluation service exists for healthcare
- +Classic 'picks and shovels' business model — profits regardless of which AI vendors win or fail
- +Low technical complexity for MVP — content/services business with simple tech layer
- +Strong network effects: more health system reviews = more valuable directory = more health systems join
- +Regulatory tailwind: FDA AI oversight increasing, EU AI Act compliance needs, all drive demand for independent evaluation
- !Credibility chicken-and-egg: health systems won't pay without proven methodology, but you can't prove methodology without health system data and access
- !KLAS could expand their AI evaluation depth at any time — they have the brand, data, and relationships already
- !Sales cycle in healthcare is brutally long (6-18 months), especially for advisory services to risk-averse procurement teams
- !Building genuine evaluation expertise requires clinical, technical, and regulatory knowledge that's hard to assemble as a solo founder
- !Vendor hostility: AI vendors whose products score poorly will push back, threaten legal action, or try to undermine credibility
- !Health system budgets are under pressure — adding another advisory subscription is a tough internal sell
Dominant healthcare IT ratings firm collecting structured feedback from 800+ health systems, producing 'Best in KLAS' rankings across AI categories like ambient AI, imaging AI, and clinical decision support.
Publishes Magic Quadrants, Hype Cycles, and Market Guides covering healthcare AI segments. Offers 1:1 analyst inquiry for health system leaders making AI purchasing decisions.
Digital health marketplace and advisory network for health systems evaluating AI and digital health solutions. Curated vendor catalog organized by clinical use case with peer reviews and implementation playbooks.
Boutique healthcare IT analyst firm producing in-depth market research reports on healthcare AI segments including ambient AI, clinical workflows, and population health analytics.
Nonprofit health technology safety evaluator historically focused on medical devices, now expanding into AI-enabled clinical tools. Provides hazard alerts, technology assessments, and safety guidance.
Launch as a free, SEO-optimized healthcare AI vendor directory (200+ vendors, structured by category: ambient scribes, imaging AI, revenue cycle AI, etc.) with basic profiles. Monetize with 3 paid 'deep dive' evaluation reports on the hottest AI categories (e.g., ambient clinical documentation, radiology AI, clinical decision support) at $2,500-$5,000 each. Each report includes 5-10 vendor evaluations with real customer reference checks, clinical outcome claims verification, and financial stability scores. Use the free directory to build traffic, email list, and credibility. Offer a 'quick vet' advisory call ($500/hour) for health systems evaluating specific vendors. The directory is the top-of-funnel; reports and advisory are the revenue.
Free vendor directory (traffic + credibility) → Paid evaluation reports ($2.5K-$5K each) → Advisory calls ($500/hr) → Annual subscription for continuous access ($15K-$50K/yr) → Enterprise advisory retainers ($50K-$100K/yr for large health systems) → Vendor-side analytics (charge vendors for anonymized buyer intent data and competitive benchmarking, $10K-$50K/yr) → Conference/events revenue
8-14 weeks to first dollar. Weeks 1-4: build directory + first evaluation report. Weeks 5-8: launch, distribute via LinkedIn/CHIME communities/health IT Slack groups, offer free samples. Weeks 8-12: first paid report sales and advisory calls. The sales cycle for enterprise subscriptions will be 6-12 months, but individual report purchases and advisory calls can happen much faster through direct outreach to CIOs/CMIOs active in online communities.
- “AI vendors and solutions are a dime a dozen”
- “select reputable vendors with some sort of track record and customer references”
- “most of these AI startups are going to flop or get acquired”
- “Choose wisely”
- “Guide your SLT with care”